{{Drugbox
| Watchedfields = changed
| verifiedrevid = 443728822
| IUPAC_name = (3''S'',5''S'',8''R'',9''S'',10''S'',13''S'',14''S'')-3-hydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,
| image = Epiandrosterone.svg
| alt = Skeletal formula of epiandrosterone
| width = 200px
| image2 = Epiandrosterone-3D-balls.png
| alt2 = Ball-and-stick model of the epiandrosterone molecule
| width2 = 225
<!--Clinical data-->
| tradename =  
| pregnancy_category =  
| legal_status =  
| routes_of_administration =  
<!--Pharmacokinetic data-->
| bioavailability =  
| metabolism =  
| excretion =  
<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 481-29-8
| ATC_prefix = none
| PubChem = 441302
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 390065
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 8TR252Z538
| ChEBI_Ref = {{ebicite|correct|EBI}}
| ChEBI = 541975
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 272195
<!--Chemical data-->
| C=19 | H=30 | O=2
| molecular_weight = 290.440 g/mol
| smiles = O=C2[C@]1(CC[C@H]3[C@H]([C@@H]1CC2)CC[C@H]4C[C@@H](O)CC[C@]34C)C
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C19H30O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h12-16,20H,3-11H2,1-2H3/t12-,13-,14-,15-,16-,18-,19-/m0/s1
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = QGXBDMJGAMFCBF-LUJOEAJASA-N
}}
'''表雄酮'''（{{lang-en|Epiandrosterone}}）或称为'''异雄酮'''（{{lang-en|isoandrosterone}}）<ref name="YalkowskyHe2016">{{cite book|author1=Samuel H. Yalkowsky|author2=Yan He|author3=Parijat Jain|title=Handbook of Aqueous Solubility Data, Second Edition|url=https://books.google.com/books?id=cfFzJFthLCIC&pg=PA1209|date=19 April 2016|publisher=CRC Press|isbn=978-1-4398-0246-5|pages=1209–}}</ref><ref name="KrishnaPrakashanMedia2006">{{cite book|title=Natural Products|url=https://books.google.com/books?id=Zb84fVthd_cC&pg=PA298|year=2006|publisher=Krishna Prakashan Media|isbn=978-81-87224-85-3|pages=298–}}</ref>是一种[[甾体激素|甾体激素]]，拥有较弱的[[雄激素|雄激素]]活性，是[[睾酮|睾酮]]和[[双氢睾酮|双氢睾酮]]（DHT）的[[代謝產物|代謝產物]]，在1931年由[[阿道夫·布特南特|阿道夫·布特南特]]和[[库尔特·切尔宁|库尔特·切尔宁]]首次分离。他们蒸馏了17000升的男性尿液，从中得到50毫克的[[雄酮|雄酮]]结晶（很可能是混合了的α/β异构体），并发现其和[[雌酮|雌酮]]有着相似的化学结构。

大部分[[哺乳动物|哺乳动物]]包括猪都能合成表雄酮<ref>Raeside JI, Renaud RL, Marshall DE. Identification of 5 alpha-androstane-3 beta,17 beta-diol and 3 beta-hydroxy-5 alpha-androstan-17-one sulfates as quantitatively significant secretory products of porcine Leydig cells and their presence in testicular venous blood. J Steroid Biochem Mol Biol. 42(1):113-20, 1992</ref>，在体内可由[[5α還原酶|5α還原酶]]催化[[肾上腺|肾上腺]]激素[[脱氢表雄酮|DHEA]]而来<ref>Callies F, Arlt W, Siekmann L, Hübler D, Bidlingmaier F, Allolio B. Influence of oral dehydroepiandrosterone (DHEA) on urinary steroid metabolites in males and females. Steroids. 65(2):98-102, 2000</ref><ref>Labrie F, Cusan L, Gomez JL, Martel C, Bérubé R, Bélanger P, Chaussade V, Deloche C, Leclaire J. Changes in serum DHEA and eleven of its metabolites during 12-month percutaneous administration of DHEA. J Steroid Biochem Mol Biol. 2008 May;110(1-2):1-9</ref><ref>Daniël Henri van de Kerkhof. Steroid profiling in doping analysis. [S.l.] : [s.n.], 2001 - Tekst. - Proefschrift Universiteit Utrecht</ref><ref>Acacio BD, Stanczyk FZ, Mullin P, Saadat P, Jafarian N, Sokol RZ. Pharmacokinetics of dehydroepiandrosterone and its metabolites after long-term daily oral administration to healthy young men. Fertil Steril. Mar;81(3):595-604, 2004</ref>，另外也可由[[3β-雄烷二醇|3β-雄烷二醇]]经[[3(或17)β-羟基类固醇脱氢酶|17β-羟基类固醇脱氢酶]]催化或[[雄烷二酮|雄烷二酮]]经[[3(或17)β-羟基类固醇脱氢酶|3β-羟基类固醇脱氢酶]]催化而来。

== 参见 ==

* [[3β-雄烷二醇|3β-雄烷二醇]]
* [[雄甾烯醇|雄甾烯醇]]
* [[雄甾烯酮|雄甾烯酮]]
* [[雌甾四烯|雌甾四烯]]

==参考文献==
{{Reflist}}
{{甾体激素}}
[[Category:激素|Category:激素]]
[[Category:哺乳动物激素|Category:哺乳动物激素]]